SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-094576
Filing Date
2024-11-05
Accepted
2024-11-05 16:15:10
Documents
14
Period of Report
2024-11-01
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0219666-8k_aditxt.htm   iXBRL 8-K 33790
2 TRANSCRIPT OF STAKEHOLDER UPDATE NOVEMBER 1, 2024 ea021966601ex99-1_aditxt.htm EX-99.1 47258
  Complete submission text file 0001213900-24-094576.txt   274509

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE adtx-20241101.xsd EX-101.SCH 3009
4 XBRL LABEL FILE adtx-20241101_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE adtx-20241101_pre.xml EX-101.PRE 22355
16 EXTRACTED XBRL INSTANCE DOCUMENT ea0219666-8k_aditxt_htm.xml XML 3784
Mailing Address 737 N. FIFTH STREET, SUITE 200 RICHMOND VA 23219
Business Address 737 N. FIFTH STREET, SUITE 200 RICHMOND VA 23219 909-488-0844
Aditxt, Inc. (Filer) CIK: 0001726711 (see all company filings)

IRS No.: 823204328 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39336 | Film No.: 241427648
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)